Explore 3 Stock Ideas & Industry Insights Download Free Report

CVS Health CDR (CAD Hedged)

Healthcare CA CVS

24.4CAD
1.12(4.81%)

Last update at 2026-06-22T19:59:00Z

Day Range

24.3924.68
LowHigh

52 Week Range

16.8420.25
LowHigh

Fundamentals

  • Previous Close 23.28
  • Market Cap101669.70M
  • Volume10525
  • P/E Ratio53.37
  • Dividend Yield14.42%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax 2136.00M 6148.00M 11173.00M 5836.00M
Minority interest 40.00M - - -
Net income 1768.00M 4614.00M 8344.00M 4311.00M
Selling general administrative 970.00M 989.00M 985.00M 745.00M
Selling and marketing expenses - - - -
Gross profit 55362.00M 51401.00M 54431.00M 54502.00M
Reconciled depreciation 4606.00M - - -
Ebit - - - -
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income 5143.00M 9007.00M 13743.00M 7954.00M
Other operating expenses - - - -
Interest expense 3119.00M - - -
Tax provision 408.00M 1562.00M 2805.00M 1509.00M
Interest income 3119.00M 2958.00M 2658.00M 2287.00M
Net interest income -3119.00000M - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 402067.00M 372809.00M 357776.00M 322467.00M
Total operating expenses 396924.00M 363802.00M 344033.00M 314513.00M
Cost of revenue 346705.00M 321408.00M 303345.00M 267965.00M
Total other income expense net -5130.00000M - - -
Discontinued operations - - - -
Net income from continuing ops 1728.00M - - -
Net income applicable to common shares 1768.00M 4614.00M 8344.00M 4311.00M
Preferred stock and other adjustments - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 253538.00M 253215.00M 249728.00M 228275.00M
Intangible assets 25508.00M 27323.00M 29234.00M 24803.00M
Earning assets - - - -
Other current assets 5091.00M 3076.00M 3151.00M 3544.00M
Total liab 178324.00M 177655.00M 173267.00M 156806.00M
Total stockholder equity 75214.00M 75560.00M 76461.00M 71469.00M
Deferred long term liab - - - -
Other current liab 1116.00M - - -
Common stock 50402.00M 49661.00M 48992.00M 48193.00M
Capital stock 50402.00M - - -
Retained earnings 61196.00M 62837.00M 61604.00M 56398.00M
Other liab - - - -
Good will 85478.00M 91272.00M 91272.00M 78150.00M
Other assets 7113.00M 8104.00M 7910.00M 7848.00M
Cash 8453.00M - - -
Cash and equivalents 8453.00M 8586.00M 8196.00M 12945.00M
Total current liabilities 88692.00M 84609.00M 79189.00M 69421.00M
Current deferred revenue - - - -
Net debt 56117.00M - - -
Short term debt 0.00000M 2119.00M 200.00M 0.00000M
Short long term debt 4068.00M - - -
Short long term debt total - - - -
Other stockholder equity 200.00M 279.00M 132.00M 255.00M
Property plant equipment 28056.00M 28937.00M 30435.00M 30745.00M
Total current assets 74714.00M 68645.00M 67858.00M 65633.00M
Long term investments 32669.00M - - -
Net tangible assets - - - -
Short term investments 2145.00M 2407.00M 3259.00M 2778.00M
Net receivables 10563.00M 9881.00M 11908.00M 8983.00M
Long term debt 59237.00M 59232.00M 57313.00M 49070.00M
Inventory 19246.00M 18107.00M 18025.00M 19090.00M
Accounts payable 17641.00M - - -
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 5119.00M - - -
Deferred long term asset charges - - - -
Non current assets total 178824.00M - - -
Capital lease obligations 15380.00M - - -
Long term debt total 60502.00M 60527.00M 58638.00M 50476.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Investments -2629.00000M - - -
Change to liabilities - - - -
Total cashflows from investing activities -5871.00000M -7613.00000M -20889.00000M -5047.00000M
Net borrowings -1779.00000M - - -
Total cash from financing activities -4940.00000M -1135.00000M 2683.00M -10516.00000M
Change to operating activities - - - -
Net income 1768.00M - - -
Change in cash -172.00000M 359.00M -4780.00000M 614.00M
Begin period cash flow 8884.00M - - -
End period cash flow 8712.00M - - -
Total cash from operating activities 10639.00M 9107.00M 13426.00M 16177.00M
Issuance of capital stock - - - -
Depreciation 4606.00M - - -
Other cashflows from investing activities -3039.00000M -4832.00000M -17858.00000M -2320.00000M
Dividends paid 3397.00M 3373.00M 3132.00M 2907.00M
Change to inventory -1267.00000M - - -
Change to account receivables -3498.00000M - - -
Sale purchase of stock 394.00M -2662.00000M -1735.00000M -2949.00000M
Other cashflows from financing activities -158.00000M -159.00000M -382.00000M -449.00000M
Change to netincome - - - -
Capital expenditures 2832.00M 2781.00M 3031.00M 2727.00M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -156839.00000M -146550.00000M -117248.00000M -101364.00000M
Stock based compensation 535.00M - - -
Other non cash items -336.00000M - - -
Free cash flow 7807.00M - - -

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CVS
CVS Health CDR (CAD Hedged)
1.12 4.81% 24.40 53.37 10.45 0.24 1.27 0.42 17.09

Reports Covered

Stock Research & News

Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health CDR (CAD Hedged)

One CVS Drive, Woonsocket, RI, United States, 02895

Key Executives

Name Title Year Born
Mr. Roger N. Farah Executive Chairman of the Board 1953
Mr. J. David Joyner CEBS President, CEO & Director 1965
Mr. Tilak Mandadi EVP of Ventures and Chief Experience & Technology Officer 1964
Ms. Heidi B. Capozzi Executive VP & Chief People Officer 1970
Mr. Prem S. Shah Pharm.D Executive VP & Group President 1980
Mr. Brian O. Newman Executive VP & CFO 1969
Mr. James David Clark Senior VP, Controller & Chief Accounting Officer 1965
Mr. David A. Falkowski Executive VP & Chief Compliance Officer NA
Mr. Samrat S. Khichi Esq. Executive VP, Chief Policy Officer & General Counsel 1967
Mr. Gustavo A. Giraldo Head of Markets of Healthcare Benefits 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.